Hospital or health organisation · founded 1881
Hackensack University Medical Center
Hackensack, United States · hackensackumc.org
- Citations, last 5 years
- 18.4k
- Works, last 5 years
- 2 510
- h-index
- 322
- Scientists listed
- 0
- Grants since 2016
- 224
Grants received
2019–2023 · research · R01
Novel bi-specific immunoprophylactics against multi-drug resistant Gram-negative bacterial infections
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2019–2020 · research · R21
Unraveling colistin resistance in Klebsiella pneumoniae
Barry Neal Kreiswirth · Hackensack University Medical Center · funded by National Institutes of Health
2019–2025 · research · R00
C5a/C5ar1 signaling in protective immunity during invasive candidiasis
Jigarkumar V Desai · Hackensack University Medical Center · funded by National Institutes of Health
2019–2023 · research · R01
Novel bi-specific immunoprophylactics against multi-drug resistant Gram-negative bacterial infections
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · U19
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2019–2024 · research · R01
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade
Jason Mathew Butler · Hackensack University Medical Center · funded by National Institutes of Health
2019–2024 · research · R01
Novel bi-specific immunotherapeutic against high-threat Gram-negative pathogens
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2019–2023 · research · R01
Critical Factors Influencing Echinocandin Resistance in Candidaglabrata
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2019–2024 · cooperative agreement · U19
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2019–2023 · research · R01
Critical Factors Influencing Echinocandin Resistance in Candidaglabrata
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2019–2024 · research · R01
Novel bi-specific immunoprophylactics against multi-drug resistant Gram-negativebacterial infections
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2019–2023 · research · R01
Critical Factors Influencing Echinocandin Resistance in Candidaglabrata
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2019–2024 · research · R01
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade
Jason Mathew Butler · Hackensack University Medical Center · funded by National Institutes of Health
2019–2023 · research · R01
Critical Factors Influencing Echinocandin Resistance in Candidaglabrata
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2019–2024 · cooperative agreement · U19
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2019–2023 · research · R01
A dual-beta-lactam strategy for treating multidrug resistant M abscessus
Barry Neal Kreiswirth · Hackensack University Medical Center · funded by National Institutes of Health
2019–2024 · cooperative agreement · U19
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2019–2024 · research · R00
Elucidating the roles of systemic and mucosal complement in protection against invasive fungal infections impacting hematopoietic cell transplant
Jigarkumar V Desai · Hackensack University Medical Center · funded by National Institutes of Health
2019–2024 · cooperative agreement · U19
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2019–2025 · research · R00
Experimental evolution of pancreatic cancer
Alvin Makohon-Moore · Hackensack University Medical Center · funded by National Institutes of Health
2019–2024 · research · R01
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade
Jason Mathew Butler · Hackensack University Medical Center · funded by National Institutes of Health
2019–2024 · research · R00
Leveraging behavioral science to improve patient understanding of advanced cancer
Heather Derry-Vick · Hackensack University Medical Center · funded by National Institutes of Health
2019–2022 · research · R21
Using Collaborative Cross mice to develop a novel model of Mycobacterium abscesses lung infection
Martin Alfons Gengenbacher · Hackensack University Medical Center · funded by National Institutes of Health
2019–2025 · research · R01
Study of Interleukin 33 as a new immunotherapy of lung cancer
Song Li · Hackensack University Medical Center · funded by National Institutes of Health
2019–2024 · research · R01
Novel bi-specific immunotherapeutic against high-threat Gram-negative pathogens
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · U19
Core E Animal Infection Models
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · U19
Core C Pharmacology
Vidmantas Petraitis · Hackensack University Medical Center · funded by National Institutes of Health
2019–2024 · cooperative agreement · U19
Novel inhibitors of bacterial cell envelope biogenesis for prophylaxis against carbapenem-resistant Enterobacteriaceae
Terry Roemer · Hackensack University Medical Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · U19
New drugs for non-tuberculous mycobacterial (NTM) lung disease in patients with cystic fibrosis
Thomas Dick · Hackensack University Medical Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · U19
Administrative Core
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · U19
Synthetic environmental peptide libraries as a source of novel antibiotics
Sean F Brady · Hackensack University Medical Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · U19
Core D In vitro Screening
Barry Neal Kreiswirth · Hackensack University Medical Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · U19
Development of novel anti-TB drugs that inhibit cell wall biosynthesis and respiration
David Alland · Hackensack University Medical Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · U19
Therapeutics for drug-resistant bacteria: aryl myxopyronins and arylalkylcarboxamido phloroglucinols
Richard H. Ebright · Hackensack University Medical Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · U19
Core B Medicinal Chemistry
Joel Stephen Freundlich · Hackensack University Medical Center · funded by National Institutes of Health
2018–2023 · research · R01
Ezh2 regulates follicular helper T cell differentiation
Weiqun Peng · Hackensack University Medical Center · funded by National Institutes of Health
2018–2023 · research · R01
Combatting natural resistance and persistence in non-TB mycobacterial disease
Thomas Dick · Hackensack University Medical Center · funded by National Institutes of Health
2018–2024 · research · R01
Combatting natural resistance and persistence in non-TB mycobacterial disease
Thomas Dick · Hackensack University Medical Center · funded by National Institutes of Health
2018–2029 · research · R01
Discovery of novel lead-target pairs and identification of all-oral bactericidal drug regimens for Mycobacterium abscessus lung disease
Thomas Dick · Hackensack University Medical Center · funded by National Institutes of Health
2018–2020 · research · R01
Modulating endothelial-specific signaling to enhance functional hematopoesis
Jason Mathew Butler · Hackensack University Medical Center · funded by National Institutes of Health